Postoperative-stimulated serum thyroglobulin measured at the time of 131I ablation is useful for the prediction of disease status in patients with differentiated thyroid carcinoma

Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer

David S. Cooper, Gerard M. Doherty, Bryan R. Haugen et al. · Thyroid · 2009 · 6.8K citations · Full text

Medicine, Oncology, Radiology +17

Estimating Risk of Recurrence in Differentiated Thyroid Cancer After Total Thyroidectomy and Radioactive Iodine Remnant Ablation: Using Response to Therapy Variables to Modify the Initial Risk Estimates Predicted by the New American Thyroid Association Staging System

R. Michael Tuttle, Hernán Tala, Jatin P. Shah et al. · Thyroid · 2010 · 933 citations · Full text

Medicine, Oncology, Surgery +16

Current Approaches to Primary Therapy for Papillary and Follicular Thyroid Cancer

Ernest L. Mazzaferri · The Journal of Clinical Endocrinology & Metabolism · 2001 · 303 citations

Medicine, Oncology, Endocrine Surgery +14

Diagnosis of neck recurrences in patients with differentiated thyroid carcinoma

Andrea Frasoldati, Marialaura Pesenti, Marco Gallo et al. · Cancer · 2002 · 288 citations

Medicine, Nuclear Medicine, Oncology +17

Diagnostic 131-Iodine Whole-Body Scan May Be Avoided in Thyroid Cancer Patients Who Have Undetectable Stimulated Serum Tg Levels After Initial Treatment

Furio Pacini, Marco Capezzone, Rossella Elisei et al. · The Journal of Clinical Endocrinology & Metabolism · 2002 · 282 citations · Full text

Medicine, Endocrinology, Surgery +17